George Church

About Veritas

We are a passionate and dynamic group of scientists, engineers, genetic counselors, business folk, and designers. Our goal: empower people to live healthier, longer.

But, our story began in the 1970s with a young student passionate about one thing, DNA. George Church's work set in motion countless genetic discoveries, including the Human Genome Project, the first initiative to map all genes in the human genome.

George, along with a group of visionaries and scientists, including leaders from Harvard Medical School's Personal Genome Project, co-founded Veritas.

Leadership Team

Mirza Cifric
Mirza Cifric

Founder and Chief Executive Officer

Life sciences entrepreneur. Formerly CEO AbVitro, Head of Corp. Dev. FORMA Therapeutics.

Preston Estep III
Preston Estep III, PhD

Founder and Chief Scientific Officer

Harvard Medical School, Church Lab PhD Director of Gerontology - Personal Genome Project - Harvard Medical School.

Jonathan Zhao
Jonathan Zhao, PhD

Founder and Managing Director, Asia

International Business leader formerly responsible for Asia strategy and new products at Amgen and Pfizer. MBA from MIT Sloan and PhD in Chemistry.

Douglas F Flood
Douglas F Flood

Chief Commercial Officer and General Counsel

Former VP, Corporate Development and General Counsel at LoJack Corporation. JD from Boston University Law School.

Tim Smith
Tim Smith

Chief Operating Officer

Former VP at Cimpress and Medullan. Former COO of True Office. BS from Cornell University. MBA from the University of Rochester.

Rodrigo Martinez
Rodrigo Martinez

Chief Marketing and Design Officer

Former Life Sciences Chief Strategist at IDEO. Former Principal at Boston Consulting Group. Co-founded Harvard Business School’s Life Sciences Project.

Dana Robin Semmel, MD
Dana Robin Semmel, MD

Lab Director

Doctor of Medicine, University of Miami School of Medicine. Former Assistant Professor, Brown University School of Medicine, and former Teaching Fellow, Boston University School of Medicine.

Birgitte Simen
Birgitte Simen, PhD

VP Product Development

Formerly senior roles with Roche Diagnostics (454 Life Sciences). PhD from University of Chicago and post-doctorate from Yale University.

Diego Martinez
Diego Martinez, PhD

Head of Bioinformatics

Former Senior Analyst at Joint Genome Institute. Human Genome Project. Postdoctoral Fellow, Broad Institute of MIT and Harvard.

Sharon Namaroff
Sharon Namaroff, CGC

Director of Clinical Services, US

ABGC board-certified genetic counselor licensed in 16 states and has over 17 years of counseling experience spanning several clinical areas.

Birgit Funke
Birgit Funke, PhD, FACMG

VP of Clinical Affairs

A board-certified clinical molecular geneticist, and also an Associate Professor of Pathology at Harvard Medical School.

Medical & Scientific Advisory Board

George Church
George Church, PhD Founder, SAB Chairman

Professor of Genetics at Harvard Medical School and MIT. Founding core member of Wyss Institute for Biologically Inspired Engineering at Harvard.

Peter Blume-Jensen
Peter Blume-Jensen, MD, PhD

Scientific leader in personalized oncology, targeted oncology therapeutics, and biomarker research. Currently CSO Xtuit. Former executive with Metamark Genetics, Daiichi Sankyo, Merck and Serono.

George Siber
George Siber, MD, PhD

Former EVP and CSO at Wyeth, Faculty at Harvard Medical School and Dana Farber. Currently Adjunct Professor of Medicine at Johns Hopkins Medical School.

Scott Patterson
Scott Patterson, PhD

Previously Amgen Executive Director, Medical Sciences, and VP, Proteomics, at Celera Genomics. Currently VP, Biomarker Sciences, at Gilead Sciences, Inc.

Scott Parazynski
Scott Parazynski, MD

Former NASA Astronaut and physiologist with expertise in human adaptation to extreme environments. Professor of Practice, Arizona State University. Product developer. Stanford MD.

Shamil Sunyaev
Shamil Sunyaev, PhD

Professor, Biomedical Informatics and Medicine, Harvard Medical School. Chair in Computational Genomics. Research Geneticist, Brigham and Women’s. Associate Member of Broad Institute.

Hans Lehrach
Hans Lehrach, PhD

Director emeritus at Max Planck Institut of Molecular Genetics, CEO/CSO Dahlem Centre for Genome Research & Medical System Biology, and Founder of Alacris Theranostics Gmbh.

Natasha Frank
Natasha Frank, MD, FACMG

Medical Geneticist and Physician Scientist. Associate Physician, Brigham and Women’s Hospital. Assistant Professor of Medicine, Harvard Medical School. Director, VA Boston Genetic Service. Associate Member, Broad Institute.

Robert C
Robert C. Green, MD, MPH

Medical Geneticist and Physician Scientist. Professor of Medicine, Division of Genetics at Brigham & Women’s Hospital and Harvard Medical School. Director of the Genomes2People Research Program. Associate Member, Broad Institute.

Board of Directors

Mirza Cifric
Mirza Cifric


Life sciences entrepreneur. Formerly CEO AbVitro, Head of Corp. Dev. FORMA Therapeutics.

Ann Merrifield
Ann Merrifield


Former President Genzyme Genetics, President Genzyme BioSurgery. Dartmouth MBA.

Peter Parker
Peter Parker


Founder, Director of LabCentral and Chairman of Boston Heart Diagnostics. 25+ years life sciences venture capital.

Judith Li
Judith Li


Partner with Lilly Asia Ventures. Formerly McKinsey’s healthcare practice. MBA Harvard Business School. BA Neurobiology from Harvard.

Our offices

Veritas (Corporate)

99 Conifer Hill Drive
Danvers, MA 01923, USA

Veritas Asia

11th Floor, LEO Building, No.2 Science & Technology Park,
Hangzhou Eco-Tech Development Area,
Hangzhou, China 310018

Room 805, Platinum Tower, 233 Taicang Road
Huangpu District, Shanghai, China 200020


We are always looking for talented individuals who might be interested in joining our passionate, energized and dedicated team of professionals. To apply for any of our current openings below, please send your resume along with a cover letter to We do not accept third party solicitation for employment.